157 related articles for article (PubMed ID: 37899202)
1. [Hematopoietic cell transplantation for monogenic inflammatory bowel disease].
Kanegane H; Tomomasa D; Tanita K
Rinsho Ketsueki; 2023; 64(9):1213-1221. PubMed ID: 37899202
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic Cell Transplantation Rescues Inflammatory Bowel Disease and Dysbiosis of Gut Microbiota in XIAP Deficiency.
Ono S; Takeshita K; Kiridoshi Y; Kato M; Kamiya T; Hoshino A; Yanagimachi M; Arai K; Takeuchi I; Toita N; Imamura T; Sasahara Y; Sugita J; Hamamoto K; Takeuchi M; Saito S; Onuma M; Tsujimoto H; Yasui M; Taga T; Arakawa Y; Mitani Y; Yamamoto N; Imai K; Suda W; Hattori M; Ohara O; Morio T; Honda K; Kanegane H
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3767-3780. PubMed ID: 34246792
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic Hematopoietic Cell Transplantation Ameliorated Asymptomatic Granulomatous and Lymphocytic Interstitial Lung Disease in a Patient With XIAP Deficiency.
Oshima M; Matsukawa Y; Ikeda Y; Sakamoto K; Taga T; Maruo Y
J Pediatr Hematol Oncol; 2024 Mar; 46(2):e191-e194. PubMed ID: 38277621
[TBL] [Abstract][Full Text] [Related]
4. Intestinal outcome of bone marrow transplantation for monogenic inflammatory bowel disease.
Morita M; Takeuchi I; Kato M; Migita O; Jimbo K; Shimizu H; Yoshimura S; Tomizawa D; Shimizu T; Hata K; Ishiguro A; Arai K
Pediatr Int; 2022 Jan; 64(1):e14750. PubMed ID: 33884705
[TBL] [Abstract][Full Text] [Related]
5. Treatment of inborn errors of immunity patients with inflammatory bowel disease phenotype by allogeneic stem cell transplantation.
Moser LM; Fekadu J; Willasch A; Rettinger E; Sörensen J; Jarisch A; Kirwil M; Lieb A; Holzinger D; Calaminus G; Bader P; Bakhtiar S
Br J Haematol; 2023 Mar; 200(5):595-607. PubMed ID: 36214981
[TBL] [Abstract][Full Text] [Related]
6. Nonclassic Inflammatory Bowel Disease in Young Infants: Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome, and Other Disorders.
Chandrakasan S; Venkateswaran S; Kugathasan S
Pediatr Clin North Am; 2017 Feb; 64(1):139-160. PubMed ID: 27894441
[TBL] [Abstract][Full Text] [Related]
7. Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.
Marsh RA; Leiding JW; Logan BR; Griffith LM; Arnold DE; Haddad E; Falcone EL; Yin Z; Patel K; Arbuckle E; Bleesing JJ; Sullivan KE; Heimall J; Burroughs LM; Skoda-Smith S; Chandrakasan S; Yu LC; Oshrine BR; Cuvelier GDE; Thakar MS; Chen K; Teira P; Shenoy S; Phelan R; Forbes LR; Chellapandian D; Dávila Saldaña BJ; Shah AJ; Weinacht KG; Joshi A; Boulad F; Quigg TC; Dvorak CC; Grossman D; Torgerson T; Graham P; Prasad V; Knutsen A; Chong H; Miller H; de la Morena MT; DeSantes K; Cowan MJ; Notarangelo LD; Kohn DB; Stenger E; Pai SY; Routes JM; Puck JM; Kapoor N; Pulsipher MA; Malech HL; Parikh S; Kang EM;
J Clin Immunol; 2019 Oct; 39(7):653-667. PubMed ID: 31376032
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic challenge of very early-onset enterocolitis in an infant with XIAP deficiency.
Girardelli M; Arrigo S; Barabino A; Loganes C; Morreale G; Crovella S; Tommasini A; Bianco AM
BMC Pediatr; 2015 Dec; 15():208. PubMed ID: 26671016
[TBL] [Abstract][Full Text] [Related]
9. Primary Immunodeficiencies Associated With Early-Onset Inflammatory Bowel Disease in Southeast and East Asia.
Sasahara Y; Uchida T; Suzuki T; Abukawa D
Front Immunol; 2021; 12():786538. PubMed ID: 35095863
[TBL] [Abstract][Full Text] [Related]
10. [Chronic or severe enteropathy and immunodeficiency: be prepared for a rara avis].
Weber K; Zeißig Y; Haag C; Schmelz R; Pazmandi J; Kalinichenko A; Boztug K; Zeißig S; Aust D; Laass MW; Schuetz C
Z Gastroenterol; 2022 Nov; 60(11):1668-1677. PubMed ID: 35297030
[TBL] [Abstract][Full Text] [Related]
11. Consequences of Identifying XIAP Deficiency in an Adult Patient With Inflammatory Bowel Disease.
Quaranta M; Wilson R; Gonçalves Serra E; Pandey S; Schwerd T; Gilmour K; Klenerman P; Powrie F; Keshav S; Travis SPL; Anderson CA; Uhlig HH
Gastroenterology; 2018 Jul; 155(1):231-234. PubMed ID: 29894681
[No Abstract] [Full Text] [Related]
12. Very early-onset inflammatory bowel disease: an integrated approach.
Sullivan KE; Conrad M; Kelsen JR
Curr Opin Allergy Clin Immunol; 2018 Dec; 18(6):459-469. PubMed ID: 30299395
[TBL] [Abstract][Full Text] [Related]
13. Targeted Sequencing and Immunological Analysis Reveal the Involvement of Primary Immunodeficiency Genes in Pediatric IBD: a Japanese Multicenter Study.
Suzuki T; Sasahara Y; Kikuchi A; Kakuta H; Kashiwabara T; Ishige T; Nakayama Y; Tanaka M; Hoshino A; Kanegane H; Abukawa D; Kure S
J Clin Immunol; 2017 Jan; 37(1):67-79. PubMed ID: 27747465
[TBL] [Abstract][Full Text] [Related]
14. Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.
Burroughs LM; Torgerson TR; Storb R; Carpenter PA; Rawlings DJ; Sanders J; Scharenberg AM; Skoda-Smith S; Englund J; Ochs HD; Woolfrey AE
J Allergy Clin Immunol; 2010 Nov; 126(5):1000-5. PubMed ID: 20643476
[TBL] [Abstract][Full Text] [Related]
15. Molecular diagnosis of childhood immune dysregulation, polyendocrinopathy, and enteropathy, and implications for clinical management.
Baxter SK; Walsh T; Casadei S; Eckert MM; Allenspach EJ; Hagin D; Segundo G; Lee MK; Gulsuner S; Shirts BH; Sullivan KE; Keller MD; Torgerson TR; King MC
J Allergy Clin Immunol; 2022 Jan; 149(1):327-339. PubMed ID: 33864888
[TBL] [Abstract][Full Text] [Related]
16. Gene regulation in inborn errors of immunity: Implications for gene therapy design and efficacy.
Ghanim HY; Porteus MH
Immunol Rev; 2024 Mar; 322(1):157-177. PubMed ID: 38233996
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study.
Barzaghi F; Amaya Hernandez LC; Neven B; Ricci S; Kucuk ZY; Bleesing JJ; Nademi Z; Slatter MA; Ulloa ER; Shcherbina A; Roppelt A; Worth A; Silva J; Aiuti A; Murguia-Favela L; Speckmann C; Carneiro-Sampaio M; Fernandes JF; Baris S; Ozen A; Karakoc-Aydiner E; Kiykim A; Schulz A; Steinmann S; Notarangelo LD; Gambineri E; Lionetti P; Shearer WT; Forbes LR; Martinez C; Moshous D; Blanche S; Fisher A; Ruemmele FM; Tissandier C; Ouachee-Chardin M; Rieux-Laucat F; Cavazzana M; Qasim W; Lucarelli B; Albert MH; Kobayashi I; Alonso L; Diaz De Heredia C; Kanegane H; Lawitschka A; Seo JJ; Gonzalez-Vicent M; Diaz MA; Goyal RK; Sauer MG; Yesilipek A; Kim M; Yilmaz-Demirdag Y; Bhatia M; Khlevner J; Richmond Padilla EJ; Martino S; Montin D; Neth O; Molinos-Quintana A; Valverde-Fernandez J; Broides A; Pinsk V; Ballauf A; Haerynck F; Bordon V; Dhooge C; Garcia-Lloret ML; Bredius RG; Kałwak K; Haddad E; Seidel MG; Duckers G; Pai SY; Dvorak CC; Ehl S; Locatelli F; Goldman F; Gennery AR; Cowan MJ; Roncarolo MG; Bacchetta R;
J Allergy Clin Immunol; 2018 Mar; 141(3):1036-1049.e5. PubMed ID: 29241729
[TBL] [Abstract][Full Text] [Related]
18. How genetic testing can lead to targeted management of XIAP deficiency-related inflammatory bowel disease.
Nielsen OH; LaCasse EC
Genet Med; 2017 Feb; 19(2):133-143. PubMed ID: 27416006
[TBL] [Abstract][Full Text] [Related]
19. Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET Registry.
LaBere B; Gutierrez MJ; Wright H; Garabedian E; Ochs HD; Fuleihan RL; Secord E; Marsh R; Sullivan KE; Cunningham-Rundles C; Notarangelo LD; Chen K
J Allergy Clin Immunol Pract; 2022 May; 10(5):1325-1333.e5. PubMed ID: 35033700
[TBL] [Abstract][Full Text] [Related]
20. Does shining a spotlight on XIAP deficiency bring the role of allogeneic HCT into better focus?
Marsh RA
J Allergy Clin Immunol; 2022 Aug; 150(2):297-298. PubMed ID: 35716950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
